Susan Smith
Fortune : 2 759 $ au 31/05/2026
Fortune : 2 759 $ au 31/05/2026
Susan Smith is currently the Chief Executive Officer at The Portland Hospital For Women & Children.
She is also the Vice Chairman at Clinuvel Pharmaceuticals Ltd., the Chairman at Evewell Group Ltd., and the Director at HCA Hope Fund.
Previously, she held the position of Chief Executive Officer at The Princess Grace Hospital and The Independent Doctors Federation.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/06/2025 | 420 ( 0 % ) | 2 759 $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Directeur/Membre du Conseil | 23/09/2019 |
Evewell Group Ltd. | Président | - |
HCA Hope Fund | Directeur/Membre du Conseil | - |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Operates hospitals | Directeur Général | - |
| Sociétés | Poste | Fin |
|---|---|---|
The Princess Grace Hospital | Directeur Général | - |
The Independent Doctors Federation | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products for patients with genetic, metabolic and life-threatening disorders | Health Technology |
The Princess Grace Hospital | |
HCA Hope Fund | |
The Independent Doctors Federation | |
The Portland Hospital For Women & Children
The Portland Hospital For Women & Children Hospital/Nursing ManagementHealth Services Operates hospitals | Health Services |
Evewell Group Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national